© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
Home 2017
Archives
UTIs: The Fourth Most Common Type of Healthcare-Associated Infection
Virtually all healthcare-associated UTIs are caused by instrumentation of the urinary tract, and 12% to 16% of adult hospital inpatients will have an indwelling...
Study: Benefits of male circumcision far exceed risks
A study in Mayo Clinic Proceedings reports that the health benefits of male circumcision exceed the risks by more than 100 to 1. Overall...
Protocol reduces complications for complex spinal surgery
A team approach reduces rates of major complications for complex spinal reconstructive surgery by two thirds, according to a report in Spine Deformity. The...
Guiding your patients through menopause
The more you know about menopause, the more you can help patients understand and cope with symptoms.
Don’t get ‘caught’ in the CAUTI trap
Catheter-associated urinary tract infections (CAUTI), the most common healthcare-associated infection, can be deadly.
Study: Dementia increases risk of incontinence
A UK study in PLOS Medicine found that people with dementia have about three times the rate of urinary incontinence and more than four...
Interstitial cystitis – chronic, common, and sometimes complicated to treat
Although painful and disruptive, interstitial cystitis often can be managed with drugs, bladder instillation and other procedures, and dietary changes. Most patients also need psychosocial support or professional counseling to deal with related stress, anxiety, depression, and frustration.
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia (pain during...
FDA approves Botox for treatment of overactive bladder
On Jan. 18, 2013, the U.S. Food and Drug Administration (FDA) approved the use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who...
Study: Online prostate cancer information may be hard for patients to understand
Although experts recommend that patient-education materials be written at the fourth-through-sixth grade level, a study published online by the Journal of Urology found that...
Restraints, patient rights, and the confused patient
Author Leah Curtin analyzes the ethics of a case of confusion and restraints.
Johnson & Johnson plans to stop selling pelvic surgical mesh implants
On June 5, multiple media outlets reported that Johnson & Johnson plans to phase out sales of surgical mesh used for pelvic organ prolapse,...
Study: Patients commonly misuse medications
A study of 75,997 urine specimen results found that 63% of patients did not have results consistent with a physician’s order. Of those with...
